STAT+: Hospital giant Ascension recorded about $1.3 billion in losses from its cyberattack
The cyberattack that forced Ascension to shut off access to its electronic health records cost…
Category: Exclusive
STAT+: Drugmakers rely on ‘use codes’ to vastly expand the nature of their patent claims, STAT analysis shows
Amid debate over potential abuse of the U.S. patent system by the pharmaceutical industry, moves…
STAT+: Top staffer on drug pricing to depart Senate Finance Committee
WASHINGTON – Shawn Bishop, the Democratic staffer who drafted much of the drug pricing portion…
.jpg)
STAT+: Former Verily executives hatch plan to invest millions in high-tech medical data
Two former Verily executives say that they are starting a new initiative, Highlander Health, to…
STAT+: Novartis to spend $200 million in further bid to boost radiopharma manufacturing, market dominance
Novartis is opening a new manufacturing facility in California and expanding an existing production site…
.jpg)
STAT+: Centene eliminates brokers’ commissions for Medicare drug plans
Health insurer Centene will not pay any commissions to brokers and agents who help people…
STAT+: Biden administration’s $3.2 billion antiviral pandemic plan is fizzling out
NEW YORK — Sixteen floors above Central Park, Kris White keeps his gentler pathogens behind…
STAT+: Tome Biosciences, once a high-flying gene-editing startup, is floundering
Buzzy gene-editing startup Tome Biosciences is floundering, just nine months after launching with $213 million…
STAT+: Former Biden White House health official joins Flagship Pioneering
WASHINGTON — Raj Panjabi has made a career out of taking on some of public…
STAT+: ‘Jerking families around’: Canceled Roche rare disease trial devastates parents, angers researchers
Roche, the Swiss pharmaceutical giant, earlier this year abruptly cancelled an international clinical trial of…
STAT+: Biotech VCs are pacing for another record-low year of fundraising amid glimpses of recovery
Life science venture capital firms are pacing for another record-low year of fundraising, potentially hindering…
STAT+: Sarepta demanded Duchenne patient advocacy group censor video critical of the company
Sarepta Therapeutics demanded a prominent patient advocacy organization censor a video that contained pointed criticism…
STAT+: Federal regulation of health data and AI expected to get a boost after HHS revamp
A little-known office within the Department of Health and Human Services is getting a shot…
STAT+: Jiankui He, creator of CRISPR-edited children, relocates to a Chinese medical tourism hub
Jiankui He, the Chinese scientist who sparked a global uproar in 2018 when he revealed…
Key disability civil rights law will get a big refresh under Sen. Bob Casey’s new bill
A key piece of disability civil rights law could get a much-needed refresh. Sen. Bob…
STAT+: CVS and its PBM agree to pay $45 million to Illinois for failing to pass drug rebates
CVS Caremark, one of the largest pharmacy benefit managers in the country, agreed to pay…
Wastewater surveillance group funded by Google founder, Bloomberg sheds dozens of testing sites
WastewaterSCAN, one of the United States’ largest private entities that provide real-time data on pathogens…
STAT+: Broad Institute, facing end of Microsoft cloud contract, shuffles data science leadership
The Broad Institute of MIT and Harvard is perhaps best known for the trailblazing work…
STAT+: A cancer care startup is making a new bet with payers and providers: only pay if it works
A cancer care navigation startup has raised $95 million from prominent tech investors to help…
STAT+: Top FDA officials weighing regulation of ultra-processed foods, internal documents show
WASHINGTON – Top Food and Drug Administration officials met multiple times earlier this year to…
STAT+: AbbVie dramatically outspent its pharma company rivals in 2023 to promote its drugs to doctors
WASHINGTON — Pharmaceutical giant AbbVie paid health care providers roughly $145.7 million last year to…
STAT+: Top Biden administration officials withdraw from Coalition for Health AI
Top Biden administration officials have withdrawn from an industry body formed to set safety standards…
STAT+: Biotech accelerator Curie.Bio extends its reach with new $380 million fund
Industry veterans Alexis Borisy and Zach Weinberg had plenty of reasons to celebrate their new…
Senators push Medicare for a PET scan pay bump
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests
WASHINGTON — A House panel is exploring holding a vote on scaled-back versions of two…
STAT+: Republican lawmakers criticize FDA’s partnership with CHAI on regulating AI in medicine
Republican lawmakers are sharply criticizing the Food and Drug Administration’s relationship with a nonprofit group…
Biden and Trump are fighting to claim credit for $35 insulin. It was actually a pharma giant’s idea
WASHINGTON — Both President Biden and former President Trump love to claim credit for getting…
STAT+: New AI for biopsies can analyze microscopic images, talk to pathologists about your tumor
To non-pathologists, the histology slide looked, as all histology slides do, a sea of mottled…
NIH wanted to make cancer research more diverse. The effort turned out to be a costly failure
Government researchers hoped to attract a more diverse group of patients for clinical research by…
STAT+: BIO to announce reorganization, senior leaders expected to depart
WASHINGTON — The Biotechnology Innovation Organization on Monday is announcing a significant restructuring accompanied by…
STAT+: Element Biosciences, an Illumina rival, on its genomics ambitions — and why it hasn’t gone public
SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit…
STAT+: NYU professors who defended vaping didn’t disclose ties to Juul, documents show
WASHINGTON – Two New York University professors collaborated directly with executives of the vaping company…
STAT+: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition
MorphoSys is dealing with an emerging safety issue related to pelabresib, the experimental treatment for…
STAT+: Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future
Christopher Boerner, 53, took over as the chief executive officer of Bristol Myers Squibb last…
STAT+: Takeda is fourth big company to leave BIO since December
WASHINGTON — Takeda Pharmaceuticals has left the biotechnology industry’s main lobbying group, the fourth departure…
STAT+: Accreditation agencies take on telehealth with new virtual care standards
In the early days of the pandemic, as social distancing forced patients out of doctors’…
STAT+: How a scientific slip-up caused a pregnant woman to get an untested treatment for preterm birth
Makena, once the only available treatment to prevent preterm birth, has had its share of…
STAT+: Cancer vaccine startup launches with $54 million, Spark veteran as CEO
A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched…
STAT+: Medicare expects to spend $3.5 billion on new Alzheimer’s drug in 2025
Medicare for the first time has estimated that a new Alzheimer’s treatment could cost the…
STAT+: Boehringer Ingelheim layoffs are a sign of dysfunctional Humira biosimilar market
WASHINGTON — Boehringer Ingelheim is laying off or relocating its sales staff for its Humira biosimilar…
STAT+: As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’
The biggest enticement that large pharmacy benefit managers offer to the employers that hire them…
STAT+: UnitedHealth is on a buying spree of outpatient surgery centers
UnitedHealth Group quietly acquired dozens of outpatient facilities in 2023, with a particular focus on…
STAT+: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships
Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching…
STAT+: Medical device lobby says it’s tired of waiting on Medicare to cover breakthrough devices
Medical technology lobby AdvaMed is fed up with the Centers for Medicare and Medicaid Services….
STAT+: Change Healthcare cyber attack outage could persist for weeks, UnitedHealth Group executive implies
The outage caused by the Change Healthcare cyberattack could last weeks, a top UnitedHealth executive…
STAT+: White House to hold a listening session on reforming pharmacy benefit managers
In a bid to combat prescription drug costs, the White House will hold a listening…
STAT+: MD Anderson tried — and failed — to resolve research credit dispute between two scientists, new documents show
Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a…
Key congressman blasts HHS for lack of cooperation on Covid-19
The Health and Human Services Department’s lack of cooperation with a congressional committee investigating the…
STAT+: Senators start work on Medicare physician payment reform
WASHINGTON — A bipartisan group of senators is starting work on legislation to reform how…
STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit
Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings…